Reversible “applause sign” secondary to diffuse large B cell lymphoma
Identifieur interne : 002356 ( Istex/Corpus ); précédent : 002355; suivant : 002357Reversible “applause sign” secondary to diffuse large B cell lymphoma
Auteurs : David A. Gallagher ; Jonathan M. Schott ; Anna Childerhouse ; Thomas Wilhelm ; Andrew N. Gale ; Anette SchragSource :
- Movement Disorders [ 0885-3185 ] ; 2008-12-15.
Url:
DOI: 10.1002/mds.22311
Links to Exploration step
ISTEX:9D21A66FDBD19A75B816EA60CDA4A479FBE20A3DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible “applause sign” secondary to diffuse large B cell lymphoma</title><author><name sortKey="Gallagher, David A" sort="Gallagher, David A" uniqKey="Gallagher D" first="David A." last="Gallagher">David A. Gallagher</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Schott, Jonathan M" sort="Schott, Jonathan M" uniqKey="Schott J" first="Jonathan M." last="Schott">Jonathan M. Schott</name><affiliation><mods:affiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Childerhouse, Anna" sort="Childerhouse, Anna" uniqKey="Childerhouse A" first="Anna" last="Childerhouse">Anna Childerhouse</name><affiliation><mods:affiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Wilhelm, Thomas" sort="Wilhelm, Thomas" uniqKey="Wilhelm T" first="Thomas" last="Wilhelm">Thomas Wilhelm</name><affiliation><mods:affiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Gale, Andrew N" sort="Gale, Andrew N" uniqKey="Gale A" first="Andrew N." last="Gale">Andrew N. Gale</name><affiliation><mods:affiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22311</idno><idno type="url">https://api.istex.fr/document/9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002356</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reversible “applause sign” secondary to diffuse large B cell lymphoma</title><author><name sortKey="Gallagher, David A" sort="Gallagher, David A" uniqKey="Gallagher D" first="David A." last="Gallagher">David A. Gallagher</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Schott, Jonathan M" sort="Schott, Jonathan M" uniqKey="Schott J" first="Jonathan M." last="Schott">Jonathan M. Schott</name><affiliation><mods:affiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Childerhouse, Anna" sort="Childerhouse, Anna" uniqKey="Childerhouse A" first="Anna" last="Childerhouse">Anna Childerhouse</name><affiliation><mods:affiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Wilhelm, Thomas" sort="Wilhelm, Thomas" uniqKey="Wilhelm T" first="Thomas" last="Wilhelm">Thomas Wilhelm</name><affiliation><mods:affiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Gale, Andrew N" sort="Gale, Andrew N" uniqKey="Gale A" first="Andrew N." last="Gale">Andrew N. Gale</name><affiliation><mods:affiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-12-15">2008-12-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2426">2426</biblScope><biblScope unit="page" to="2428">2428</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D</idno><idno type="DOI">10.1002/mds.22311</idno><idno type="ArticleID">MDS22311</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>David A. Gallagher MRCP</name><affiliations><json:string>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Jonathan M. Schott MD, MRCP</name><affiliations><json:string>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Anna Childerhouse MB, ChB</name><affiliations><json:string>Department of Histopathology, Royal Free Hospital, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Thomas Wilhelm MD</name><affiliations><json:string>Department of Radiology, Royal Free Hospital, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Andrew N. Gale MD, FRCP</name><affiliations><json:string>Department of Neurology, Royal Free Hospital, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Anette Schrag MD, PhD</name><affiliations><json:string>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</json:string><json:string>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</json:string></affiliations></json:item></author><genre><json:string>Serial article</json:string></genre><host><volume>23</volume><pages><total>3</total><last>2428</last><first>2426</first></pages><issn><json:string>0885-3185</json:string></issn><issue>16</issue><subject><json:item><value>Letter</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><language><json:string>eng</json:string></language><qualityIndicators><score>5.05</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractCharCount>0</abstractCharCount><pdfWordCount>7031</pdfWordCount><pdfCharCount>46929</pdfCharCount><pdfPageCount>12</pdfPageCount><abstractWordCount>0</abstractWordCount></qualityIndicators><title>Reversible “applause sign” secondary to diffuse large B cell lymphoma</title><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/mds.22311</json:string></doi><id>9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Reversible “applause sign” secondary to diffuse large B cell lymphoma</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2008</date></publicationStmt><notesStmt><note>The Parkinson's Disease Society, United Kingdom</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Reversible “applause sign” secondary to diffuse large B cell lymphoma</title><author><persName><forename type="first">David A.</forename><surname>Gallagher</surname><roleName type="degree">MRCP</roleName></persName><affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</affiliation></author><author><persName><forename type="first">Jonathan M.</forename><surname>Schott</surname><roleName type="degree">MD, MRCP</roleName></persName><affiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</affiliation></author><author><persName><forename type="first">Anna</forename><surname>Childerhouse</surname><roleName type="degree">MB, ChB</roleName></persName><affiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</affiliation></author><author><persName><forename type="first">Thomas</forename><surname>Wilhelm</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</affiliation></author><author><persName><forename type="first">Andrew N.</forename><surname>Gale</surname><roleName type="degree">MD, FRCP</roleName></persName><affiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</affiliation></author><author><persName><forename type="first">Anette</forename><surname>Schrag</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</p></note><affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</affiliation><affiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-12-15"></date><biblScope unit="vol">23</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2426">2426</biblScope><biblScope unit="page" to="2428">2428</biblScope></imprint></monogr><idno type="istex">9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D</idno><idno type="DOI">10.1002/mds.22311</idno><idno type="ArticleID">MDS22311</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Letter</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2008-12-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="160"><doi origin="wiley" registered="yes">10.1002/mds.v23:16</doi><numberingGroup><numbering type="journalVolume" number="23">23</numbering><numbering type="journalIssue">16</numbering></numberingGroup><coverDate startDate="2008-12-15">15 December 2008</coverDate></publicationMeta><publicationMeta level="unit" type="letter" position="250" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22311</doi><idGroup><id type="unit" value="MDS22311"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="articleCategory">Letter</title><title type="tocHeading1">Letters to the Editor Related to New Topics</title></titleGroup><copyright ownership="thirdParty">Copyright © 2008 Movement Disorder Society</copyright><eventGroup><event type="publishedOnlineEarlyUnpaginated" date="2008-10-14"></event><event type="firstOnline" date="2008-10-14"></event><event type="publishedOnlineFinalForm" date="2008-12-21"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-21"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">2426</numbering><numbering type="pageLast">2428</numbering></numberingGroup><correspondenceTo>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22311.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="5"></count><count type="wordTotal" number="1336"></count></countGroup><titleGroup><title type="main" xml:lang="en">Reversible “applause sign” secondary to diffuse large B cell lymphoma</title><title type="short" xml:lang="en">Letters to the Editor</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>David A.</givenNames><familyName>Gallagher</familyName><degrees>MRCP</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Jonathan M.</givenNames><familyName>Schott</familyName><degrees>MD, MRCP</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Anna</givenNames><familyName>Childerhouse</familyName><degrees>MB, ChB</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Thomas</givenNames><familyName>Wilhelm</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Andrew N.</givenNames><familyName>Gale</familyName><degrees>MD, FRCP</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af6 #af7" corresponding="yes"><personName><givenNames>Anette</givenNames><familyName>Schrag</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email>a.schrag@medsch.ucl.ac.uk</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="GB" type="organization"><unparsedAffiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="GB" type="organization"><unparsedAffiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="GB" type="organization"><unparsedAffiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="GB" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af8" countryCode="GB" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af9" countryCode="GB" type="organization"><unparsedAffiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af10" countryCode="GB" type="organization"><unparsedAffiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af11" countryCode="GB" type="organization"><unparsedAffiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af12" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af13" countryCode="GB" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af14" countryCode="GB" type="organization"><unparsedAffiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</unparsedAffiliation></affiliation></affiliationGroup><fundingInfo><fundingAgency>The Parkinson's Disease Society, United Kingdom</fundingAgency></fundingInfo><supportingInformation><p> Additional Supporting Information may be found in the online version of this article. </p><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds22311:22311"></mediaResource><caption>Segment 1. Patient demonstrating positive applause sign. Segment 2. Applause sign resolved following chemotherapy.</caption></supportingInfoItem></supportingInformation></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Reversible “applause sign” secondary to diffuse large B cell lymphoma</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Letters to the Editor</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Reversible “applause sign” secondary to diffuse large B cell lymphoma</title></titleInfo><name type="personal"><namePart type="given">David A.</namePart><namePart type="family">Gallagher</namePart><namePart type="termsOfAddress">MRCP</namePart><affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jonathan M.</namePart><namePart type="family">Schott</namePart><namePart type="termsOfAddress">MD, MRCP</namePart><affiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anna</namePart><namePart type="family">Childerhouse</namePart><namePart type="termsOfAddress">MB, ChB</namePart><affiliation>Department of Histopathology, Royal Free Hospital, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Thomas</namePart><namePart type="family">Wilhelm</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Radiology, Royal Free Hospital, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Andrew N.</namePart><namePart type="family">Gale</namePart><namePart type="termsOfAddress">MD, FRCP</namePart><affiliation>Department of Neurology, Royal Free Hospital, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anette</namePart><namePart type="family">Schrag</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</affiliation><affiliation>Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom</affiliation><description>Correspondence: Department of Clinical Neurosciences, Royal Free Campus, Institute of Neurology, University College London, London, United Kingdom</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">letter</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2008-12-15</dateIssued><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="references">5</extent><extent unit="words">1336</extent></physicalDescription><note type="funding">The Parkinson's Disease Society, United Kingdom</note><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> Additional Supporting Information may be found in the online version of this article.Supporting Info Item: Segment 1. Patient demonstrating positive applause sign. Segment 2. Applause sign resolved following chemotherapy. - </note><subject><genre>article category</genre><topic>Letter</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>16</number></detail><extent unit="pages"><start>2426</start><end>2428</end><total>3</total></extent></part></relatedItem><identifier type="istex">9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D</identifier><identifier type="DOI">10.1002/mds.22311</identifier><identifier type="ArticleID">MDS22311</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002356 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002356 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:9D21A66FDBD19A75B816EA60CDA4A479FBE20A3D
|texte= Reversible “applause sign” secondary to diffuse large B cell lymphoma
}}
| This area was generated with Dilib version V0.6.23. |  |